Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$33.78 - $63.75 $3.5 Million - $6.6 Million
-103,588 Reduced 26.25%
291,086 $9.86 Billion
Q1 2024

May 03, 2024

BUY
$60.14 - $75.36 $3.1 Million - $3.89 Million
51,595 Added 15.04%
394,674 $25.7 Billion
Q4 2023

Feb 07, 2024

BUY
$42.85 - $69.5 $14.7 Million - $23.8 Million
343,079 New
343,079 $23.4 Billion

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.